Hurler’s syndrome gene therapy (Christie Hospital)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHurler’s syndrome gene therapy (Christie Hospital)
Drug Alias Namealpha-L-iduronidase gene therapy (Paterson/Christie)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK Manchester Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research UK Manchester Institute
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A